Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 07-2012 | 04-2012 | 01-2012 | 10-2011 | 07-2011 | |
| Sales | 494 | 145 | 249 | 128 | 360 |
| Cost of Goods | 229 | 143 | 145 | -37 | 185 |
| Gross Profit | 265 | 2 | 104 | 165 | 174 |
| Operating Expenses | 138 | 162 | 170 | 139 | 351 |
| Operating Income | 127 | -160 | -66 | 25 | -177 |
| Interest Expense | 59 | 60 | 53 | 106 | 58 |
| Other Income | -68 | -12 | 119 | 82 | -18 |
| Pre-tax Income | N/A | -232 | N/A | 1 | -253 |
| Net Income Continuous | 68 | -232 | -119 | 1 | -253 |
| Net Income | $68 | $-232 | $-119 | $1 | $-253 |
| EPS Basic Total Ops | 0.00 | -0.27 | -0.27 | 0.00 | -0.55 |
| EPS Basic Continuous Ops | 0.00 | -0.27 | -0.27 | 0.00 | -0.55 |
| EPS Diluted Total Ops | 0.00 | -0.27 | -0.27 | 0.00 | -0.55 |
| EPS Diluted Continuous Ops | 0.00 | -0.27 | -0.27 | 0.00 | -0.55 |
| EBITDA(a) | $300 | $-133 | $0 | $193 | $-120 |